XRpro Sciences, Inc.·4

Feb 2, 12:53 PM ET

XRpro Sciences, Inc. 4

4 · XRpro Sciences, Inc. · Filed Feb 2, 2015

Insider Transaction Report

Form 4
Period: 2015-01-07
Transactions
  • Award

    Stock options

    2015-01-07+500,000500,000 total
    Exercise: $1.75From: 2015-11-24Exp: 2025-01-06Common Stock (500,000 underlying)
Footnotes (2)
  • [F1]Pursuant to the terms of Mr. Cunningham's employment agreement (the "Employment Agreement") with XRpro Sciences Inc. (f/k/a Caldera Pharmaceuticals, Inc.) (the "Company"), Mr. Cunningham was awarded options exercisable for 500,000 shares of the Company's common stock on the closing date of the Company's first financing subsequent to Mr. Cunningham becoming the Company's President and Chief Executive Officer.
  • [F2]The options vest as follows: (i) 100,000 options vest on November 24, 2015; (ii) 300,000 options vest monthly on a pro rata basis commencing on the last day of months thirteen (13) through forty eight (48) of the term of the Employment Agreement, which ends on November 24, 2018, unless terminated earlier; and (iii) 100,000 options vest on November 24, 2018.

Documents

1 file
  • 4
    f4010715cunningham_xrpro.xmlPrimary

    OWNERSHIP DOCUMENT